[ORGANIZATION]
Eli Lilly and Company
Featured in 6 tracked stories · first seen
Situations
Brazil ANVISA expands product safety enforcement
20 clusters · 162 sources · last updated
Latest: Brazil's Anvisa orders recall of Paramol batch and seizes counterfeit Mounjaro
Since May 2026 Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics and other consumer goods. Early actions suspended batches of statins, dexa
Also covered in
-
Global Oncology Innovation and Biotech Job Opportunities Highlighted
[HEALTH] · 2 sources ·
-
Eli Lilly partners with Resilience on $750 million US drug‑manufacturing expansion
[BUSINESS] · 9 sources ·
-
Novo Nordisk Faces Shareholder Lawsuit Over CagriSema Trial
[BUSINESS] · 4 sources ·
-
Eli Lilly shares rise 2.1% on analyst upgrades; MercadoLibre to report Q2 2026 earnings; Elicio Therapeutics forecasts a
[BUSINESS] · 4 sources ·
-
Plug Power hydrogen stock slump and pharma picks spotlighted by analysts
[BUSINESS] · 3 sources ·